3-Minute Breakdowns

Two Healthcare Stocks I'm Watching Now - 3-Minute Stock Analysis

3-Minute Breakdowns

3-Minute Breakdowns

11-28-2025

DESCRIPTION
Published first at https://www.3minutebreakdowns.com Two healthcare stocks I'm watching now. Dutch biotech company Uniqure soared over 300% in September after releasing data that showed positive results for its treatment of Huntington’s disease. Uniqure’s experimental gene therapy is delivered directly into the brain and the company’s 3 year study showed a 75% slowing progression of the devastating disease. The news was greeted with euphoria and hailed as a stunning breakthrough by the scientific community. And the therapy could also be highly lucrative for Uniqure with gene therapy treatments often costing upwards of 2 millions dollars. However, on November 3rd, Uniqure stock gave back almost all its gains as it emerged the FDA would no longer accept the company’s data as robust enough to support a BLA submission. Investors scaled back their bets as a new study could take years to develop. ABOUT ME Joe is the original founder of 3-minute Breakdowns and editor for Overlooked Alpha, the number one newsletter for overlooked investing ideas and stock market analysis. Joe evaluates companies from a business-first perspective, searching for things that the market has got wrong and waiting for the 'fat pitch'. LINKS My website: https://www.3minutebreakdowns.com/ Koyfin charts: https://www.koyfin.com/affiliate/overlooked-alpha/?via=3mb TikTok: https://www.tiktok.com/@overlookedalpha X: https://x.com/OverlookedAlpha DISCLAIMER & DISCLOSURE This content is for educational and entertainment purposes only. 3-Minute Breakdowns is not a registered investment advisor and does not provide financial recommendations (only opinions). The information is being presented without consideration of the investment objectives, risk tolerance, or financial circumstances of any specific investor and might not be suitable for all investors. Past performance is not indicative of future results. All investing involves risk, including the possible loss of principal. The author reserves the right to buy and sell or change his position in a particular stock at any time. This description contains affiliate links that allow you to find the items that I personally use and recommend. Thank you for your support.

In Queue

UP NEXT
Should you buy Intel stock? (March 2024)

Should you buy Intel stock? (March 2024)

3-12-2024

Alphabet Stock Analysis (August 2023)

Alphabet Stock Analysis (August 2023)

8-1-2023

I just bought this stock (Procore Technologies)

I just bought this stock (Procore Technologies)

3-28-2024

AMD Stock Analysis (December 2023)

AMD Stock Analysis (December 2023)

12-20-2023